{"log_id": 3618523047335545951, "direction": 0, "words_result_num": 36, "words_result": [{"probability": {"variance": 0.002438, "average": 0.985607, "min": 0.6983}, "location": {"width": 749, "top": 124, "height": 36, "left": 313}, "words": "对老年流感患者,磷酸奥司他韦治疗较安慰剂能减少需抗生素治疗的下呼吸道并发症"}, {"probability": {"variance": 0.014313, "average": 0.942025, "min": 0.426056}, "location": {"width": 791, "top": 162, "height": 39, "left": 280}, "words": "〔主要是支气管炎)的发生率,分别为磷酸奥司他韦组12(29/250)和安慰剂组19%(52/268)"}, {"probability": {"variance": 0.00418, "average": 0.95581, "min": 0.80228}, "location": {"width": 103, "top": 216, "height": 25, "left": 285}, "words": "(p=0.0156)"}, {"probability": {"variance": 0.000412, "average": 0.99291, "min": 0.878197}, "location": {"width": 758, "top": 244, "height": 37, "left": 312}, "words": "对合并有慢性心脏或/和呼吸道疾病的流感患者,需抗生素治疗的下呼吸道并发症的发"}, {"probability": {"variance": 0.004386, "average": 0.964903, "min": 0.720628}, "location": {"width": 803, "top": 285, "height": 37, "left": 268}, "words": "生率分别为磷酸奥司他韦组14%(16/118)和安慰剂组17%(22133),组间无统计学差异"}, {"probability": {"variance": 0.000167, "average": 0.989241, "min": 0.961795}, "location": {"width": 106, "top": 339, "height": 21, "left": 281}, "words": "p=0.5975"}, {"probability": {"variance": 0.02512, "average": 0.901874, "min": 0.440063}, "location": {"width": 264, "top": 375, "height": 28, "left": 316}, "words": "病毒神经氨酸酶敏感性的降低"}, {"probability": {"variance": 0.009823, "average": 0.959139, "min": 0.409189}, "location": {"width": 749, "top": 410, "height": 38, "left": 313}, "words": "在自然获得性流感的临床试验中,0.34%4/1177)的成人和青少年及4.5%(17/374)"}, {"probability": {"variance": 0.007416, "average": 0.970079, "min": 0.56247}, "location": {"width": 776, "top": 449, "height": 36, "left": 273}, "words": "的1-12岁儿童中出现一过性甲型流感病毒的神经氨酸酶对奥司他韦羧酸盐的敏感性下降"}, {"probability": {"variance": 0.002728, "average": 0.977975, "min": 0.758691}, "location": {"width": 792, "top": 490, "height": 35, "left": 273}, "words": "在细胞培养和临床试验中均来发现乙型流感病毒的神经氨酸酶对奥司他韦羧酸盐的敏感性"}, {"probability": {"variance": 0.000139, "average": 0.988086, "min": 0.976288}, "location": {"width": 41, "top": 540, "height": 23, "left": 277}, "words": "下降"}, {"probability": {"variance": 0.001265, "average": 0.986796, "min": 0.811687}, "location": {"width": 755, "top": 568, "height": 36, "left": 316}, "words": "体外实验发现扎那米韦耐药的流感突变株和奥司他韦耐药的流感突变株有交叉耐药。临"}, {"probability": {"variance": 0.000476, "average": 0.991558, "min": 0.894944}, "location": {"width": 486, "top": 612, "height": 34, "left": 273}, "words": "床中未发现足够的证据证实有奥司他韦耐药或交叉耐药"}, {"probability": {"variance": 0.002653, "average": 0.984993, "min": 0.682327}, "location": {"width": 734, "top": 650, "height": 34, "left": 318}, "words": "目前的流感预防的临床试验中,包括流感接触后预防(7天)和季节性预防(42天)"}, {"probability": {"variance": 0.000658, "average": 0.985839, "min": 0.903076}, "location": {"width": 485, "top": 692, "height": 32, "left": 275}, "words": "无证据显示应用奥司他韦会引起相关的耐药病毒株出现"}, {"probability": {"variance": 0.036465, "average": 0.918324, "min": 0.450677}, "location": {"width": 144, "top": 736, "height": 25, "left": 321}, "words": "乙星流感的治疗"}, {"probability": {"variance": 0.010973, "average": 0.966824, "min": 0.553943}, "location": {"width": 751, "top": 769, "height": 34, "left": 319}, "words": "总体上15%的流感患者是乙型流感病毒感染,在各个试验中所占的比例为1-33%。各个"}, {"probability": {"variance": 0.00976, "average": 0.969991, "min": 0.413559}, "location": {"width": 795, "top": 808, "height": 36, "left": 276}, "words": "试验中乙型流感患者的中位疾病持续时间在各治疗组之间无显著差别。把所有试验的乙型"}, {"probability": {"variance": 0.003405, "average": 0.980814, "min": 0.684533}, "location": {"width": 800, "top": 850, "height": 32, "left": 274}, "words": "流感患者504例汇总分析,与安慰剂组相比,奥司他韦可以使所有症状的持续时间缩短0.7"}, {"probability": {"variance": 0.00875, "average": 0.95071, "min": 0.560105}, "location": {"width": 793, "top": 888, "height": 35, "left": 275}, "words": "天(95%可信区间为0.1-1.6天:p=0.022),使发热、咳嗽和流涕的持续时间缩短1天(95%"}, {"probability": {"variance": 0.004182, "average": 0.978122, "min": 0.684779}, "location": {"width": 314, "top": 933, "height": 28, "left": 278}, "words": "可信区间为0.4-1.7天,p<0.001)"}, {"probability": {"variance": 9.2e-05, "average": 0.991676, "min": 0.970154}, "location": {"width": 185, "top": 974, "height": 27, "left": 323}, "words": "本品与达菲生物等效"}, {"probability": {"variance": 0.00386, "average": 0.956511, "min": 0.821382}, "location": {"width": 115, "top": 1016, "height": 26, "left": 286}, "words": "【药理毒理】"}, {"probability": {"variance": 0.008676, "average": 0.973873, "min": 0.419585}, "location": {"width": 756, "top": 1049, "height": 34, "left": 320}, "words": "磷酸奥司他是其活性代谢产物的药物前体,其活性代谢产物(奥司他韦羧酸盐)是选"}, {"probability": {"variance": 0.000922, "average": 0.986636, "min": 0.837569}, "location": {"width": 793, "top": 1088, "height": 37, "left": 282}, "words": "择性的流感病毒神经氨酸酶抑制剂。神经氨酸酶是病毒表面的一种糖蛋白酶,其活性对新形"}, {"probability": {"variance": 0.012725, "average": 0.96176, "min": 0.455244}, "location": {"width": 691, "top": 1129, "height": 37, "left": 281}, "words": "成的病毒颗粒从被感染细胞中释放和感染性病毒在人体内进一步播散室关"}, {"probability": {"variance": 0.0185, "average": 0.946203, "min": 0.413011}, "location": {"width": 752, "top": 1170, "height": 34, "left": 323}, "words": "磷酸奥司他韦的活性代谢产物能够抑制甲型和乙型流感病神酸酶性选体外"}, {"probability": {"variance": 0.025817, "average": 0.936852, "min": 0.367727}, "location": {"width": 796, "top": 1209, "height": 40, "left": 280}, "words": "对病毒神经氨酸酶活性的半数抑制浓度低至纳克水平在体外观察到活性代谢产物制流感"}, {"probability": {"variance": 0.00238, "average": 0.983743, "min": 0.762328}, "location": {"width": 525, "top": 1254, "height": 37, "left": 281}, "words": "病毒生长,在体内也观察到其抑制流感病毒的复制和病性"}, {"probability": {"variance": 0.047171, "average": 0.858073, "min": 0.436874}, "location": {"width": 651, "top": 1290, "height": 71, "left": 324}, "words": "本品通过抑制病毒从被感染的细胞中释放,减少买型惑1"}, {"probability": {"variance": 0.01229, "average": 0.948668, "min": 0.412737}, "location": {"width": 755, "top": 1337, "height": 36, "left": 324}, "words": "对白然获得的和实验室性流行性感冒进行的哪显:应用磷酸并没有影响人"}, {"probability": {"variance": 0.010592, "average": 0.946889, "min": 0.557435}, "location": {"width": 800, "top": 1373, "height": 44, "left": 284}, "words": "体对感染产生正常的体液免疫反应。对灭活疫苗的抗体反应并没有受气他市治疗的影"}, {"probability": {"variance": 0, "average": 0.804358, "min": 0.804358}, "location": {"width": 23, "top": 1432, "height": 23, "left": 286}, "words": "响"}, {"probability": {"variance": 0.023192, "average": 0.787464, "min": 0.635175}, "location": {"width": 101, "top": 1453, "height": 159, "left": 250}, "words": "新升"}, {"probability": {"variance": 0.006837, "average": 0.962647, "min": 0.760471}, "location": {"width": 141, "top": 1529, "height": 27, "left": 614}, "words": "第9页共11页"}, {"probability": {"variance": 0.003287, "average": 0.92899, "min": 0.863184}, "location": {"width": 183, "top": 1581, "height": 67, "left": 266}, "words": "质量管理章"}], "language": 3}